|
C4ORF21 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.29229960066368E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.84810000028557E-07 |
| Normal-vs-Stage2 |
1.306070E-02 |
| Normal-vs-Stage3 |
4.824600E-03 |
| Normal-vs-Stage4 |
1.863780E-01 |
| Stage1-vs-Stage2 |
6.584800E-01 |
| Stage1-vs-Stage3 |
7.210200E-01 |
| Stage1-vs-Stage4 |
8.907000E-01 |
| Stage2-vs-Stage3 |
5.095600E-01 |
| Stage2-vs-Stage4 |
7.211400E-01 |
| Stage3-vs-Stage4 |
9.332800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.07190034626115E-10 |
| Normal-vs-AfricanAmerican |
6.161100E-04 |
| Normal-vs-Asian |
2.881600E-01 |
| Caucasian-vs-AfricanAmerican |
4.663500E-02 |
| Caucasian-vs-Asian |
5.867200E-01 |
| AfricanAmerican-vs-Asian |
4.593800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.82900036729927E-10 |
| Normal-vs-Female |
1.64999999999749E-05 |
| Male-vs-Female |
2.810600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.142700E-03 |
| Normal-vs-Extreme_Weight |
6.55649999958818E-07 |
| Normal-vs-Obese |
2.07070000000087E-05 |
| Normal-vs-Extreme_Obese |
4.427800E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.171800E-01 |
| Normal_Weight-vs-Obese |
7.183600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.104200E-01 |
| Extreme_Weight-vs-Obese |
8.551200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.214200E-01 |
| Obese-vs-Extreme_Obese |
9.085400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.336500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.88969995207344E-09 |
| Normal-vs-Age(61-80Yrs) |
5.39870000038079E-07 |
| Normal-vs-Age(81-100Yrs) |
1.024050E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.519600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.039200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.864600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.532400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.716200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.650400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.42129657937562E-11 |
| Normal-VS-Type2 PRCC |
5.571800E-02 |
| Normal-VS-KIRP CIMP |
3.000100E-02 |
| Normal-VS-Unclassified PRCC |
8.14530000000646E-05 |
| Type1 PRCC-VS-Type2 PRCC |
6.358000E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.581600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.456200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.837180E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.409620E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.346200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.596250E-03 |
| Normal-vs-N1 |
3.200400E-03 |
| Normal-vs-N2 |
3.343400E-01 |
| N0-vs-N1 |
5.222200E-01 |
| N0-vs-N2 |
7.818000E-01 |
| N1-vs-N2 |
5.530800E-01 |
|
|
